Project MISSION: Developing a multicomponent, Multilevel Implementation Strategy for Syncope OptImalCare thrOugh eNgagement
Project MISSION: Developing a multicomponent, Multilevel Implementation Strategy for Syncope OptImalCare thrOugh eNgagement
批准号:
9755244
负责人:
Jing Li
金额:
$50.94万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-08-15 至 2021-07-31
关键词:
Academic Medical CentersAccident and Emergency departmentActivities of Daily LivingAdherenceAdoptedAdoptionAdultAffectAmericanAmerican Heart AssociationAssessment toolAtrial FibrillationAttitudeCardiacCardiologyCardiovascular systemCaringCharacteristicsChronic low back painClimateClinicalClinical Practice GuidelineCollaborationsCommunity HospitalsComplexDangerousnessDataDiagnosisDiagnosticDistressEffectivenessEmergency Department PhysicianEmergency MedicineEmergency department visitEtiologyEvaluationEventFunctional disorderGoalsGuidelinesHealthHospitalizationHospitalsHybridsImpairmentInterviewKnowledgeMediatingMedicineMental HealthMorbidity - disease rateOrganizational CultureOrthostatic HypotensionParticipantPatient-Focused OutcomesPatientsPerceptionPopulationPrevalenceProcessProviderPublic HealthQuality of lifeReadinessRecommendationRecurrenceReflex actionReportingResearchRheumatoid ArthritisRiskSocial EnvironmentSocietiesStandardizationStructureSurveysSymptomsSyncopeSystemTestingTimeTranslationsUnconscious StateVasovagalWorkadverse outcomebaseclinical careclinical practicecollegecommon symptomdesignevidence baseexperienceheart rhythmhigh riskimplementation researchimplementation strategyimplementation trialimprovedmortalitymortality risknoveloutcome forecastphysical conditioningsocial organizationtool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Abstract
Syncope is a complex presenting symptom that requires thoughtful and efficient evaluation to
determine the etiology of a patient's loss of consciousness. Prevalence rates of syncope have been reported
as high as 41%, with recurrent syncope occurring in 13.5%. A common symptom, approximately 1% to 3% of
all emergency department (ED) visits (as many ED visits as atrial fibrillation) and up to 6% of all hospital
admissions are due to syncope. The prognosis among patients with syncope depends on the etiology and
underlying cardiovascular condition. A cardiac etiology of syncope is associated with significantly higher rates
of morbidity and mortality than other causes such as vasovagal reflex mediated or orthostatic hypotension. The
Framingham study documented a doubling of the risk of death among participants with cardiac syncope
compared with those with non-cardiac syncope. Notably, experiencing syncope affects patients' quality of life
(QoL), and those with more frequent syncope report poorer QoL with perceptions of low overall physical and
mental health and impairment in activities of daily living. The QoL among patients with recurrent syncope
appears equivalent to severe rheumatoid arthritis and chronic low-back pain in an adult population. Though
research in the past 25 years provides substantial understanding of the pathophysiology of particular etiologies
of syncope, the diagnostic approach to such a perplexing symptom remains difficult and efficient diagnosis
remains elusive.
The major challenge in the evaluation of patients with syncope is that most patients are asymptomatic
at the time of their presentation. Because of concerns that patients presenting with syncope are at risk for an
impending catastrophic event, overuse and inappropriate use of testing and hospital admission are common.
Aiming to provide guidance on optimizing the evaluation and management of syncope, a collaboration of the
American College of Emergency Physicians, Society for Academic Emergency Medicine, American College of
Cardiology (ACC), American Heart Association (AHA) and Heart Rhythm Society (HRS) issued a Guideline for
the Evaluation and Management of Patients with Syncope in 2017. Adopting a standardized approach to
syncope based on this guideline offers an effective opportunity for delivering high value care to patients
suffering this distressing and potentially dangerous event. Aiming for more rapid translation from guideline to
clinical practice and improved health, the proposed study will identify barriers and facilitators for
implementation of an evidence-based, high value approach to diagnosis and management of patients
presenting with syncope. The research team will develop a multi-level, multi-component implementation
strategy for evidence-based syncope evaluation and management and plan for a subsequent hybrid
effectiveness-implementation trial, guided by the Consolidated Framework for Implementation Research
(CFIR).
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1016/j.ajem.2020.05.029
发表时间:
2020-09
期刊:
The American journal of emergency medicine
影响因子:
--
作者:
[Li J, Gupta V, Smyth SS, Cowley A, Du G, Sirrine M, Stearley S, Chadha R, Bhalla V, Williams MV]
通讯作者:
Williams MV
DOI:
10.2196/25192
发表时间:
2021-11-16
期刊:
Journal of medical Internet research
影响因子:
7.4
作者:
[Amin S, Gupta V, Du G, McMullen C, Sirrine M, Williams MV, Smyth SS, Chadha R, Stearley S, Li J]
通讯作者:
Li J
DOI:
10.2147/ppa.s307186
发表时间:
2021
期刊:
Patient preference and adherence
影响因子:
2.2
作者:
[Clouser JM, Sirrine M, McMullen CA, Cowley AM, Smyth SS, Gupta V, Williams MV, Li J]
通讯作者:
Li J
DOI:
10.3390/medicina57060570
发表时间:
2021-06-03
期刊:
Medicina (Kaunas, Lithuania)
影响因子:
--
作者:
[Li J, Smyth SS, Clouser JM, McMullen CA, Gupta V, Williams MV]
通讯作者:
Williams MV
Identifying Guideline-Practice Gaps to Optimize Evaluation and Management for Patients With Syncope.
DOI:
10.1016/j.cjca.2020.05.022
发表时间:
2021-03
期刊:
The Canadian journal of cardiology
影响因子:
--
作者:
[Smyth S, Gupta V, Williams M, Cowley A, Sirrine M, Surratt H, Chadha R, Stearley S, Bhalla V, Li J]
通讯作者:
Li J
AIDen: An AI-empowered detection and diagnosis system for jaw lesions using CBCT
-
批准号:10383494
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2022
-
负责人:Jing Li
-
依托单位:
Physiologically Based Pharmacokinetic Modeling of Drug Penetration into the Human Brain and Brain Tumors
-
批准号:10674753
-
项目类别:
-
资助金额:$36.94万
-
财政年份:2021
-
负责人:Jing Li
-
依托单位:
Physiologically Based Pharmacokinetic Modeling of Drug Penetration into the Human Brain and Brain Tumors
-
批准号:10459595
-
项目类别:
-
资助金额:$37.32万
-
财政年份:2021
-
负责人:Jing Li
-
依托单位:
Physiologically Based Pharmacokinetic Modeling of Drug Penetration into the Human Brain and Brain Tumors
-
批准号:10298016
-
项目类别:
-
资助金额:$39.43万
-
财政年份:2021
-
负责人:Jing Li
-
依托单位:
Effect of Medicare Reimbursement for Care Planning on End of Life Care among Patients with Alzheimer's Disease and Related Dementias: A Quasi-Experimental Study
-
批准号:10172824
-
项目类别:
-
资助金额:$12.58万
-
财政年份:2020
-
负责人:Jing Li
-
依托单位:
Effect of Medicare Reimbursement for Care Planning on End of Life Care among Patients with Alzheimer's Disease and Related Dementias: A Quasi-Experimental Study
-
批准号:10677882
-
项目类别:
-
资助金额:$12.81万
-
财政年份:2020
-
负责人:Jing Li
-
依托单位:
Effect of Medicare Reimbursement for Care Planning on End of Life Care among Patients with Alzheimer's Disease and Related Dementias: A Quasi-Experimental Study
-
批准号:10408777
-
项目类别:
-
资助金额:$0.92万
-
财政年份:2020
-
负责人:Jing Li
-
依托单位:
Effect of Medicare Reimbursement for Care Planning on End of Life Care among Patients with Alzheimer's Disease and Related Dementias: A Quasi-Experimental Study
-
批准号:10690298
-
项目类别:
-
资助金额:$11.6万
-
财政年份:2020
-
负责人:Jing Li
-
依托单位:
Impact of the Physician Payments Sunshine Act on Prescription Drug Utilization and Spending
-
批准号:9807060
-
项目类别:
-
资助金额:$9.99万
-
财政年份:2019
-
负责人:Jing Li
-
依托单位:
Development of nucleic acid delivery platform based on polymeric CXCR4 antagonists
-
批准号:9045744
-
项目类别:
-
资助金额:$34.75万
-
财政年份:2016
-
负责人:Jing Li
-
依托单位:
Multi-Modality Image Data Fusion and Machine Learning Approaches for Personalized Diagnostics and Prognostics of MCI due to AD
-
批准号:10264079
-
项目类别:
-
资助金额:$121.97万
-
财政年份:2016
-
负责人:Jing Li
-
依托单位:
Toward new classification criteria for mild and moderate TBI by a data-inclusive cross-study analysis using FITBIR
-
批准号:9320986
-
项目类别:
-
资助金额:$18.86万
-
财政年份:2016
-
负责人:Jing Li
-
依托单位:
Pharmacology
-
批准号:8350775
-
项目类别:
-
资助金额:$4.34万
-
财政年份:2011
-
负责人:Jing Li
-
依托单位:
Multi-point and multi-locus analysis of genomic association data
-
批准号:7897811
-
项目类别:
-
资助金额:$93.03万
-
财政年份:2006
-
负责人:Jing Li
-
依托单位:
Efficient Analysis of SNPs & Haplotypes with Applications in Gene Mapping
-
批准号:7020438
-
项目类别:
-
资助金额:$42.28万
-
财政年份:2006
-
负责人:Jing Li
-
依托单位:
Efficient Analysis of SNPs & Haplotypes with Applications in Gene Mapping
-
批准号:7209009
-
项目类别:
-
资助金额:$39.39万
-
财政年份:2006
-
负责人:Jing Li
-
依托单位:
Multi-point and multi-locus analysis of genomic association data
-
批准号:7652746
-
项目类别:
-
资助金额:$95.1万
-
财政年份:2006
-
负责人:Jing Li
-
依托单位:
Pharmacology
-
批准号:8600867
-
项目类别:
-
资助金额:$4.63万
-
财政年份:--
-
负责人:Jing Li
-
依托单位:
Shared Resource: Pharmacology
-
批准号:8997280
-
项目类别:
-
资助金额:$7.69万
-
财政年份:--
-
负责人:Jing Li
-
依托单位:
Pharmacology
-
批准号:8780610
-
项目类别:
-
资助金额:$4.51万
-
财政年份:--
-
负责人:Jing Li
-
依托单位: